CAMPANINI, Nicoletta
 Distribuzione geografica
Continente #
NA - Nord America 3.856
AS - Asia 3.237
EU - Europa 2.329
SA - Sud America 483
AF - Africa 187
Continente sconosciuto - Info sul continente non disponibili 177
OC - Oceania 7
Totale 10.276
Nazione #
US - Stati Uniti d'America 3.745
SG - Singapore 1.115
CN - Cina 795
IT - Italia 783
VN - Vietnam 533
BR - Brasile 366
IE - Irlanda 305
SE - Svezia 288
HK - Hong Kong 220
BD - Bangladesh 184
DE - Germania 149
FR - Francia 143
FI - Finlandia 139
ZA - Sudafrica 123
GB - Regno Unito 110
NL - Olanda 98
TR - Turchia 84
UA - Ucraina 72
IN - India 66
CA - Canada 65
RU - Federazione Russa 59
AT - Austria 53
JP - Giappone 36
AR - Argentina 34
IQ - Iraq 32
KR - Corea 31
BE - Belgio 29
CO - Colombia 29
MX - Messico 26
PL - Polonia 25
ID - Indonesia 21
EC - Ecuador 19
CI - Costa d'Avorio 18
PH - Filippine 18
ES - Italia 16
UZ - Uzbekistan 14
TH - Thailandia 13
VE - Venezuela 13
LT - Lituania 11
PK - Pakistan 11
CZ - Repubblica Ceca 10
MA - Marocco 10
RO - Romania 10
PY - Paraguay 9
CL - Cile 8
SA - Arabia Saudita 7
AZ - Azerbaigian 6
EG - Egitto 5
KE - Kenya 5
KZ - Kazakistan 5
LB - Libano 5
TN - Tunisia 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
AU - Australia 4
CG - Congo 4
DZ - Algeria 4
ET - Etiopia 4
EU - Europa 4
IL - Israele 4
BS - Bahamas 3
CR - Costa Rica 3
HN - Honduras 3
HU - Ungheria 3
IR - Iran 3
JM - Giamaica 3
JO - Giordania 3
LV - Lettonia 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
PT - Portogallo 3
BH - Bahrain 2
BO - Bolivia 2
BZ - Belize 2
CY - Cipro 2
DK - Danimarca 2
KG - Kirghizistan 2
NG - Nigeria 2
NO - Norvegia 2
PA - Panama 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
UY - Uruguay 2
AM - Armenia 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LR - Liberia 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
Totale 10.089
Città #
Singapore 614
Ashburn 504
Chandler 368
San Jose 368
Dublin 305
Santa Clara 291
Dallas 217
Hong Kong 211
Beijing 186
Ho Chi Minh City 152
Council Bluffs 137
Parma 130
Hanoi 126
New York 122
Ann Arbor 116
Johannesburg 115
Boardman 107
Los Angeles 101
Shanghai 84
Hefei 74
Dearborn 71
Jacksonville 67
Lauterbourg 64
Izmir 62
Nanjing 51
Milan 50
Princeton 48
Munich 47
Vienna 47
Buffalo 41
São Paulo 37
Wilmington 35
Bologna 34
Tokyo 32
Moscow 29
Rio Saliceto 28
Brussels 27
Haiphong 27
Toronto 27
Chicago 26
Da Nang 26
Helsinki 25
Modena 25
Rome 25
Warsaw 23
Columbus 22
San Mateo 22
Atlanta 21
Orem 21
Jinan 20
Sant'Ilario d'Enza 20
Houston 19
Montreal 19
Seoul 19
Woodbridge 19
Abidjan 18
Chennai 18
Guangzhou 18
London 18
Bremen 17
Nanchang 17
Shenyang 16
The Dalles 16
Turku 16
Bogotá 15
Hebei 15
Marseille 15
Nuremberg 15
Phoenix 14
Poplar 14
Reggio Emilia 14
Changsha 13
Jakarta 13
Kunming 13
San Francisco 13
Amsterdam 12
Baghdad 12
Florence 12
Naples 12
Stockholm 12
Tashkent 12
Boston 11
Des Moines 11
Hải Dương 11
Seattle 11
Denver 10
Rio de Janeiro 10
Brooklyn 9
Can Tho 9
Charlotte 9
Pune 9
Sissa 9
Tianjin 9
Bangkok 8
Bari 8
Brasília 8
Campinas 8
Chengdu 8
Dhaka 8
Frankfurt am Main 8
Totale 6.058
Nome #
Lymphocyte Sub-population in Rectal Biopsies of Horses with Recurrent Colics and Malabsorption (Unhappy Hindgut Syndrome): A Preliminary Study on Morphology and Immune Microenvironment After Recovery 274
LINFOCITI INFILTRANTI IL TUMORE, BAP-1, VEGFR-2 E IGF-1R NEL MESOTELIOMA PLEURICO MALIGNO 272
Case Report: Irreversible Watery Diarrhea, Severe Metabolic Acidosis, Hypokalemia and Achloridria Syndrome Related to Vasoactive Intestinal Peptide Secreting Malignant Pheochromocytoma 217
Immunohistochemical Detection of Hematopoietic Cell-specific Protein-Tyrosine Phosphatase (Tyrosine Phosphatase SHP-1) in a Series of Endometrioid and Serous Endometrial Carcinoma 216
Neuroendocrine Small Cell Carcinoma of the Cervix: A case report 214
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab 213
Immunohistochemical expression of Mesothelin in a series of high grade tubal-ovarian serous carcinoma 211
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology? 203
Immunomodulatory effects of antiangiogenic tyrosine kinase inhibitors in renal cell carcinoma models: Impact on following anti-PD-1 treatments 202
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo 192
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy 189
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 187
PREDICTIVE AND PROGNOSTIC VALUE OF CLINICAL AND MOLECULAR FEATURES IN PATIENTS UNDERGOING PULMONARY METASTASECTOMY FROM RENAL CELL CARCINOMA 186
Hypoxia-Inducible Factor (HIF)-1 alpha Inhibitionin Myeloma Cells Significantly Increases the Anti-Myeloma Effect of Lenalidomide in Vivo 184
Immunohistochemical expression of Napsin A in normal human foetal lungs and congenital and acquired pathologic conditions 181
Pulmonary metastasectomy for colorectal cancer: Analysis of prognostic factors affecting survival 180
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 180
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability 179
Clinicopathological implications of the epidermal growth factor receptor, Cylooxygenase-2 expression and human papilloma virus status in squamous cell carcinoma of the uterine cervix in the elderly 175
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors 165
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial 164
Glial transporter EAAT2 and glutamatergic turnover in humna neocortex. An immunohistochemical study 164
Analysis of COX-2 expression in Wilms' Tumour. 161
Anticorpo monoclonale per diagnosi e trattamento di tumori canini 160
Immunohistochemical expression of Napsin A in normal human fetal lungs at different gestational ages and in acquired and congenital pathological pulmonary conditions. 160
Ag-NORs, nucleus-nucleolus-associated antigens (Ki67, PCNA, P-105 and p-120): prognostic markers of meningioma recurrence 159
C-kit expression in Wilms' tumour: An immunohistochemical study 158
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity 157
Expression of the glial glutamate transporter EAAT2 in normal ageing 157
On the human amygdaloid body in normal ageing. The aminoacidergic system 154
Galectin-1 Is Highly Expressed By Myeloma Cells and the Bone Marrow Microenvironment and Its Suppression Delineates a New Therapeutic in Vitro and in Vivo Strategy in Multiple Myeloma 152
Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC 151
Molecular classification using Lund University algorithm and clinical correlations in muscle-invasive bladder cancer: Insights from a retrospective study 150
COVID-19 in pregnancy: placental pathological patterns and effect on perinatal outcome in five cases. 150
Immune context characterization and heterogeneity in primary tumors and pulmonary metastases from renal cell carcinoma 150
Clinicopathological implications of the epidermal growth factor receptor, Cylooxygenase-2 expression and human papilloma virus status in squamous cell carcinoma of the uterine cervix in the elderly 149
Grading the neuroendocrine tumors of the lung: an evidence-based proposal. 146
Histopathological lesions of the gastrointestinal tract associated with the use of polystyrene sulfonate and sevelamer: a meta-analysis 145
Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts 144
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016) 139
Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study 139
Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment 138
On the myoepithelium of human salivary glands. An immunocytochemical study 137
PROGNOSTIC SIGNIFICANCE OF NM23 GENE PRODUCT EXPRESSION IN PATIENTS WITH COLORECTAL CARCINOMA TREATED WITH RADICAL INTENT 137
Optimizing PD-L1 evaluation on cytological samples from advanced non-small-cell lung cancer 136
Drug-induced glutamine depletion hinders the growth of beta- catenin mutated human liver cancer xenografts 134
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin 132
TUMOR-INFILTRATING LYMPHOCYTES, PDL-1, BAP-1, VEGFR-2 AND IGF-1R EXPRESSION IN MALIGNANT PLEURAL MESOTHELIOMA 130
GHRELIN PROTECTS AGAINST ETHANOL-INDUCED GASTRIC ULCERS IN RATS: STUDIES ON THE MECHANISMS OF ACTION 128
Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review 125
TUMOUR-INFILTRATING LYMPHOCYTES AND BAP-1, VEGFR-2 AND IGF-1R EXPRESSION IN MALIGNANT PLEURAL MESOTHELIOMA 124
Peanut-like 1 (septin 5) gene expression in normal and neoplastic human endocrine pancreas 118
HIF-1α expression by immunohistochemistry and mRNA-210 levels by real time polymerase chain reaction in post-mortem cardiac tissues: A pilot study 117
Thymidylate synthase, topoisomerase-1 and microsatellite instability: relationship with outcome in mucinous colorectal cancer treated with fluorouracil. 116
7P STK11 and Galectin-3 tissue expression entails a prognostic signature in immunotherapy treated NSCLC patients 115
Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents 110
Glutamine synthetase immunostaining correlates with pathologic features of hepatocellular carcinoma and better survival after radiofrequency thermal ablation 109
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 107
The future potential of genome-wide mutational profiles in HRD detection in breast cancer 106
Gleason grading of prostate carcinoma in neddle biopsies vs. radical prostatectomy specimens 102
MYELOMA CELLS FROM THE BONE MARROW TO THE SKIN: HOW? 102
Th9 cells and allergic dermatitis 99
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 98
Impact of preoperative chemoradiotherapy on tumor infiltrating lymphocytes in locally advanced rectal cancer: The SMART-STAR study 96
Immunological and molecular correlates of disease recurrence after liver resection for hepatocellular carcinoma. 94
High Prognostic Value of 68Ga-PSMA PET/CT in Renal Cell Carcinoma and Association with PSMA Expression Assessed by Immunohistochemistry 71
RAD51 as a biomarker for homologous recombination deficiency in high-grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test 65
Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making 61
Anticorpo biparatopico diretto verso NG2/CSPG4 e i suoi usi 36
Temporal patterns of neutrophil recruitment and microthrombus formation in fatal traumatic brain injury: a forensic histopathological study 4
Totale 10.276
Categoria #
all - tutte 35.507
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.507


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022315 0 0 23 44 15 10 57 31 12 20 18 85
2022/20231.261 91 161 70 104 117 140 15 94 385 26 47 11
2023/2024609 33 56 55 37 44 134 45 33 27 34 35 76
2024/20251.857 66 82 126 121 218 213 122 80 174 202 164 289
2025/20264.358 351 336 463 413 585 256 424 170 573 355 262 170
2026/2027464 107 213 144 0 0 0 0 0 0 0 0 0
Totale 10.276